期刊文献+

重症肺炎患者血清磷水平与30d病死率的相关性研究 被引量:6

Study on correlation between serum phosphorus level and 30-day mortality rate in patients with severe pneumonia
下载PDF
导出
摘要 目的探讨重症肺炎患者血清磷水平与30d病死率的相关性。方法将2014年1月至2015年10月于该院呼吸科住院治疗的80例重症肺炎患者纳入本研究,根据30d死亡事件,分为死亡组(n=30)和存活组(n=50)。比较血清磷,急性生理学与慢性健康状况评价系统(APACHEⅡ)评分,肺部感染(CPIS)评分,英国胸科协会改良肺炎评分(CURB-65评分),感染相关器官衰竭评估(SOFA)评分以及肺炎严重指数(PSI)评分水平差异。结果死亡组患者血清磷水平低于存活组患者(P<0.05)。ROC曲线分析提示血清磷、APACHEⅡ评分和CURB-65评分的预测30d死亡事件的AUC分别为0.732、0.664和0.682。相关性分析提示血清磷水平与30d死亡事件呈负相关(r=-0.566,P<0.05)、CURB-65评分(r=-0.392,P<0.05)和PSI评分(r=-0.235,P<0.05)呈负相关。Logistics回归分析提示血清磷小于0.030 mmol/L(OR=1.56)和CURB-65评分大于3.9(OR=1.15)为MACE发生的独立危险因素。结论重症肺炎患者入院时血清磷水平与30d病死率密切相关。 Objective To investigate the correlation between serum phosphorus level and 30‐day mortality rate in the patients with severe pneumonia(SP) .Methods Consecutive 80 SP patients in the respiration department our hospital from January 2014 to October 2015 were enrolled in this study and divided into the survival group(n= 50) and death group(n= 30) based on the 30‐day death events .The serum phosphorus level ,APACHE II score ,CPIS score ,CURB‐65 score ,SOFA score and PSI score were com‐pared between the two groups .Results The phosphorus level in the death group was significantly lower than that in the survival group[(0 .37 ± 0 .06) mmol/L vs .(0 .61 ± 0 .05) mmol/L ,P 3 .9 ,OR = 1 .15) were the independent risk factors of major adverse cardiovascular event (MACE) occurrence .Conclusion The serum phosphorus level at admission is closely related with 30‐day mortality rate in SP patients .
作者 李静 尉俊生
出处 《检验医学与临床》 CAS 2016年第18期2607-2609,2612,共4页 Laboratory Medicine and Clinic
关键词 重症肺炎 血清磷 30d病死率 severe pneumonia serum phosphorus 30-day mortality
  • 相关文献

参考文献4

二级参考文献41

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3048
  • 2Houck PM,Bratzler DW,Nsa W,et al.Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community acquired pneumonia[J].Arch Intern Med,2004,164(6):637-644.
  • 3Fine MJ,Smith MA,Carson CA,et al.Prognosis and outcomes of patients with community-acquired pneumonia[J].A meta-analysis.JAMA,1996,275(2):134-141.
  • 4Lim WS,van der Eerden MM,Laing R,et al.Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study[J].Thorax,2003,58(5):377-382.
  • 5Menendez R,Torres A,Zalacain R,et al.Risk factors of treatment nonresponse in community acquired pneumonia:implications for disease outcome[J].Thorax,2004,59(11):960-965.
  • 6Niederman MS,Feldman C,Richards GA,et al.Combining information from prognostic scoring tools for CAP:an American view on how to get the best of all worlds[J].Eur Respir J,2006,27(1):9-11.
  • 7Bugg NC, Jones JA. Hypophosphataemia: pathophysiology, effects and management on the intensive care unit. Anaesthesia, 1998,53 : 895-902.
  • 8Geerse DA, Bindels A J, Kuiper MA, et al. Treatment of hypophos- phatemia in the intensive care unit:a review. Crit Care, 2010,14: R147.
  • 9Hoffmann M,Zemlin AE,Meyer WP,et al. Hypophosphataemia at a large academic hospital in South Africa. J Clin Pathol,2008,61 : 1104-1107.
  • 10Mehanna HM, Moledina J,Travis J. Refeeding syndrome:what it is, and how to prevent and treat it.BMJ, 2008,336:1495-1498.

共引文献79

同被引文献54

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部